scholarly journals A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression

2011 ◽  
pp. 2791 ◽  
Author(s):  
Tong-Rong Jan ◽  
Shen ◽  
Liang ◽  
Wang ◽  
Liao
Nano Select ◽  
2021 ◽  
Author(s):  
Ramis Arbi ◽  
Amr Ibrahim ◽  
Liora Goldring‐Vandergeest ◽  
Kunyu Liang ◽  
Greg Hanta ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (16) ◽  
pp. 4143
Author(s):  
Philipp Boosz ◽  
Felix Pfister ◽  
Rene Stein ◽  
Bernhard Friedrich ◽  
Lars Fester ◽  
...  

T cell infiltration into a tumor is associated with a good clinical prognosis of the patient and adoptive T cell therapy can increase anti-tumor immune responses. However, immune cells are often excluded from tumor infiltration and can lack activation due to the immune-suppressive tumor microenvironment. To make T cells controllable by external forces, we loaded primary human CD3+ T cells with citrate-coated superparamagnetic iron oxide nanoparticles (SPIONs). Since the efficacy of magnetic targeting depends on the amount of SPION loading, we investigated how experimental conditions influence nanoparticle uptake and viability of cells. We found that loading in the presence of serum improved both the colloidal stability of SPIONs and viability of T cells, whereas stimulation with CD3/CD28/CD2 and IL-2 did not influence nanoparticle uptake. Furthermore, SPION loading did not impair cytokine secretion after polyclonal stimulation. We finally achieved 1.4 pg iron loading per cell, which was both located intracellularly in vesicles and bound to the plasma membrane. Importantly, nanoparticles did not spill over to non-loaded cells. Since SPION-loading enabled efficient magnetic accumulation of T cells in vitro under dynamic conditions, we conclude that this might be a good starting point for the investigation of in vivo delivery of immune cells.


2020 ◽  
Vol 46 (05) ◽  
pp. 553-562
Author(s):  
Joshua Talev ◽  
Jagat Rakesh Kanwar

AbstractAtherosclerosis is the major cause of cardiovascular diseases and is the leading cause of mortality worldwide. Iron oxide nanoparticles have emerged as potential diagnostic and therapeutic agents for a wide range of conditions. To date, the theranostic applications of iron oxide nanoparticles have been studied mainly in cancer, but atherosclerosis has not received the same attention. Therefore, it appears appropriate to review the current and future applications of iron oxide nanoparticles for the diagnosis and therapy of atherosclerosis. This review will first discuss current imaging techniques for the diagnosis of atherosclerosis as well as their limitations. It will then discuss the role of nanotechnology for molecular imaging of atherosclerosis and the benefits of this approach as well as reviewing current developments in the field including single, bi-, and tri-modal imaging. Next, it will discuss the role of nanotechnology for therapies of atherosclerosis with a focus on nanotheranostics, concluding with a look at the challenges faced by nanoparticle-based imaging and therapy of atherosclerosis as well as a look at future prospects.


2021 ◽  
Author(s):  
Ryosuke Nozawa ◽  
Takashi Naka ◽  
Masato Kurihara ◽  
Takanari Togashi

Size of monodisperse iron oxide nanoparticles are turned via continuous seed mediated growth via stepwise thermal decomposition of iron(ii) oxalate in small volume alkylamine mixture.


Sign in / Sign up

Export Citation Format

Share Document